In Veritas Medical Diagnostics, Inc.
IVME · OTC
1/31/2008 | 10/31/2007 | 7/31/2007 | 4/30/2007 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $156 | $203 | $252 | $128 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $194 | $164 | $661 | $315 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $350 | $368 | $914 | $443 |
| Operating Income | $350 | $368 | $914 | $443 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$275 | -$288 | -$241 | -$253 |
| Pre-Tax Income | -$625 | -$656 | -$1,155 | -$697 |
| Tax Expense | -$700 | -$735 | -$1,828 | -$886 |
| Net Income | -$625 | -$656 | -$1,155 | -$697 |
| % Margin | – | – | – | – |
| EPS | -0.01 | -0.011 | -0.019 | -0.012 |
| % Growth | 5.5% | 43.6% | -68% | – |
| EPS Diluted | -0.01 | -0.011 | -0.019 | -0.012 |
| Weighted Avg Shares Out | 60,418 | 60,266 | 59,706 | 60,373 |
| Weighted Avg Shares Out Dil | 60,418 | 60,266 | 59,706 | 60,373 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $275 | $0 | $0 | $253 |
| Depreciation & Amortization | $1 | $1 | $0 | $2 |
| EBITDA | -$349 | -$367 | -$914 | -$441 |
| % Margin | – | – | – | – |